Projects

Our projects focus on developing innovative diagnostic tools based on metabolomic profiling and machine learning:

• MAMA Test, a prenatal screening validated through clinical trials and published in AJOG;
• Medea Test, tackling endometrial cancer through ensemble machine learning;
• CD-GEMM, examining the microbiome’s role in celiac disease development;
• GEMMA, a project unraveling genetic, environmental, and microbial triggers in Autism Spectrum Disorder.

Collaborations

We believe that progress is accelerated through partnership.
Over the years, we’ve established significant collaborations with public and private research institutions, including leading universities across Europe.

These partnerships give us access to top-tier scientific expertise and infrastructure, enabling impactful, multidisciplinary research.
Our collaborative spirit is central to how we innovate, validate, and scale our scientific contributions.

Publications

Our scientific footprint includes:

• 87 journal papers;
• 32 conference proceedings;
• 8 books;
• 12 patents.

These publications reflect our commitment to evidence-based science, spanning fields such as prenatal testing, oncology, microbiome analysis, and neurodevelopmental disorders.

Thesis support

In parallel with high-level research, we actively support academic training. We mentor and guide students through their theses, particularly in the fields of metabolomics and scientific research.

Our belief in fostering future minds is reflected in the long-term academic impact we've had through tailored mentorship, project guidance, and real-world research exposure.